• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定原料药中普乐沙福及其相关杂质的稳健耐用的稳定性指示高效液相色谱法

Robust and Rugged Stability-Indicating HPLC Method for the Determination of Plerixafor and Its Related Impurities in Drug Substances.

作者信息

Bapatu Hanimi Reddy, Maram Ravi Kumar, Murthy R Satyanarayana

机构信息

Department of Chemistry, JNT University, Kukatpally, Hyderabad, Telangana, India

Department of Chemistry, JNT University, Kukatpally, Hyderabad, Telangana, India.

出版信息

J Chromatogr Sci. 2015 Oct;53(9):1432-42. doi: 10.1093/chromsci/bmv029. Epub 2015 Apr 8.

DOI:10.1093/chromsci/bmv029
PMID:25858970
Abstract

A novel, reversed-phase high-performance liquid chromatographic method was developed and validated for the determination of related substances in Plerixafor (PLX) drug substance. PLX is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients. The method is efficient for estimation of all degradation and process-related impurities. The method was developed using the Phenomenex Luna L11 column using the gradient program with mobile phase A and mobile phase B, where mobile phase A consists of pH 2.0 1-heptanesulfonic acid sodium salt buffer and acetonitrile in the ratio of 80:20 (v/v) and mobile phase B consists of pH 2.0 1-heptanesulfonic acid sodium salt buffer and acetonitrile in the ratio of 20:80 (v/v). PLX and its impurities were monitored at 210 nm. The present work is describing the role of ion-pair reagent in the separation of polar compounds. PLX was subjected to various stress conditions of oxidative, acid, base, hydrolytic, thermal, humidity and photolytic degradations. The degradation products were well separated from each other and with the main peak, demonstrating the stability-indicating power of the method. The performance of the method was validated according to the present ICH guidelines for specificity, limit of detection, limit of quantification, linearity, accuracy, precision, ruggedness and robustness.

摘要

开发并验证了一种新型反相高效液相色谱法,用于测定普乐沙福(PLX)原料药中的有关物质。PLX是一种免疫刺激剂,用于动员癌症患者体内的造血干细胞。该方法可有效评估所有降解杂质和工艺相关杂质。该方法采用菲罗门Luna L11色谱柱,使用流动相A和流动相B的梯度程序,其中流动相A由pH 2.0的1-庚烷磺酸钠盐缓冲液和乙腈按80:20(v/v)的比例组成,流动相B由pH 2.0的1-庚烷磺酸钠盐缓冲液和乙腈按20:80(v/v)的比例组成。在210 nm波长处监测PLX及其杂质。本研究描述了离子对试剂在极性化合物分离中的作用。PLX经受了氧化、酸、碱、水解、热、湿度和光解等各种强制降解条件。降解产物彼此之间以及与主峰均得到了很好的分离,证明了该方法的稳定性指示能力。该方法的性能根据现行ICH指南进行了特异性、检测限、定量限、线性、准确度、精密度、耐用性和稳健性的验证。

相似文献

1
Robust and Rugged Stability-Indicating HPLC Method for the Determination of Plerixafor and Its Related Impurities in Drug Substances.用于测定原料药中普乐沙福及其相关杂质的稳健耐用的稳定性指示高效液相色谱法
J Chromatogr Sci. 2015 Oct;53(9):1432-42. doi: 10.1093/chromsci/bmv029. Epub 2015 Apr 8.
2
Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.建立并验证了一种新型的 HPLC 稳定性指示法,用于定量测定依泽替米贝原料药及制剂中十一相关物质。
Talanta. 2015 Jul 1;139:67-74. doi: 10.1016/j.talanta.2015.02.039. Epub 2015 Feb 27.
3
UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.超高效液相色谱法(UPLC)和液相色谱 - 质谱联用(LC - MS)对盐酸伊立替康降解行为的研究以及开发一种经验证的稳定性指示超高效液相色谱法,用于测定药物剂型中盐酸伊立替康及其杂质。
J Chromatogr Sci. 2012 Oct;50(9):810-9. doi: 10.1093/chromsci/bms075. Epub 2012 Jun 1.
4
Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form.用于原料药和药物剂型中萘普生及其杂质测定的新型经验证的稳定性指示超高效液相色谱法
Sci Pharm. 2012 Oct-Dec;80(4):965-76. doi: 10.3797/scipharm.1207-12. Epub 2012 Sep 9.
5
A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms.一种用于原料药及药物制剂中兰索拉唑及其杂质测定的新型、经过验证的稳定性指示超高效液相色谱法。
Sci Pharm. 2013 Jan-Mar;81(1):183-93. doi: 10.3797/scipharm.1210-09. Epub 2012 Dec 3.
6
Quantification of halobetasol propionate and its impurities present in topical dosage forms by stability-indicating LC method.采用稳定性指示液相色谱法对局部用剂型中丙酸氯倍他索及其杂质进行定量分析。
J Chromatogr Sci. 2015 Jan;53(1):127-34. doi: 10.1093/chromsci/bmu029. Epub 2014 Apr 30.
7
A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection.一种用于测定治疗丙型肝炎感染的药物达卡他韦中潜在杂质及其质量的稳定性指示超高效液相色谱法,采用新型QDa质量检测器。
J Chromatogr Sci. 2019 Jan 1;57(1):44-53. doi: 10.1093/chromsci/bmy079.
8
A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.一种用于眼用剂型中盐酸多佐胺和马来酸噻吗洛尔相关物质的新颖且快速验证的稳定性指示超高效液相色谱法。
J Chromatogr Sci. 2012 Oct;50(9):745-55. doi: 10.1093/chromsci/bms025. Epub 2012 May 4.
9
Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.建立一种 HPLC 法用于同时测定富马酸沃诺拉赞原料药中十种有关物质的含量。
J Pharm Biomed Anal. 2018 Feb 5;149:133-142. doi: 10.1016/j.jpba.2017.11.011. Epub 2017 Nov 4.
10
A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.一种新型反相稳定性指示 RP-UPLC 法,用于定量测定雷诺嗪原料药和制剂中的十五种有关物质。
Talanta. 2012 Aug 15;97:563-73. doi: 10.1016/j.talanta.2012.03.067. Epub 2012 Apr 25.

引用本文的文献

1
Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.共递纳米胶束通过协同重塑 CAFs 介导的肿瘤基质和重新编程免疫抑制微环境来增强三阴性乳腺癌免疫治疗。
Int J Nanomedicine. 2023 Jul 31;18:4329-4346. doi: 10.2147/IJN.S418100. eCollection 2023.